Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology
Reproductive BioMedicine Online · 2024
DOI: 10.1016/j.rbmo.2024.103850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024. Verfasst von Siun Gallagher und 18 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Health Ethics, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. E…. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Marketing of Health Services, Commerce. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
RESEARCH QUESTION: What are the views and experiences of patient and expert stakeholders on the positive and negative impacts of commercial influences on the provision of assisted reproductive technology (ART) services, and what are their suggestions for governance reforms? DESIGN: Semi-structured interviews were conducted with 31 ART industry experts from across Australia and New Zealand and 25 patients undergoing ART from metropolitan and regional Australia, between September 2020 and September 2021. Data were analysed using thematic analysis. RESULTS: Expert and patient participants considered that commercial forces influence the provision of ART in a number of positive ways - increasing sustainability, ensuring consistency in standards and providing patients with greater choice. Participants also considered commercial forces to have a number of negative impacts, including increased costs to government and patients; the excessive use of interventions that lack sufficient evidence to be considered part of standard care; inadequately informed consent (particularly with regard to financial information); and threats to patient-provider relationships and patient-centred care. Participants varied in whether they believed that professional self-regulation is sufficient. While recognizing the benefits of commercial investment in healthcare, many considered that regulatory reforms, as well as organizational cultural initiatives, are needed as means to ensure the primacy of patient well-being. CONCLUSIONS: The views expressed in this study should be systematically and critically examined to derive insights into how best to govern ART. These insights may also inform the design and delivery of other types of healthcare that are provided in the private sector.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney Health Ethics, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: siun.gallagher@sydney.edu.au.
- Sydney Health Ethics, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Deakin University, Burwood, Victoria, Australia.
- Monash Bioethics Centre, School of Philosophical, Historical and International Studies, Monash University, Clayton, Victoria, Australia.
- Sydney Health Ethics, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Haematology Department, Royal North Shore Hospital, St Leonards, New So…
- Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, UK.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Gallagher, S., Attinger, S., Sassano, A., Sutton, E., Kerridge, I., Newson, A., Farsides, B., Hammarberg, K., Hart, R., Jackson, E., Ledger, W., Mayes, C., Mills, C., Norcross, S., Norman, R. J., Rombauts, L., Waldby, C., Yazdani, A., & Lipworth, W. (2024). Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2024.103850
Vancouver
Gallagher S, Attinger S, Sassano A, Sutton E, Kerridge I, Newson A, et al. Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology. Reproductive BioMedicine Online. 2024. doi:10.1016/j.rbmo.2024.103850
BibTeX
@article{Gallagher2024,
author = {Gallagher, Siun and Attinger, Sara and Sassano, Angie and Sutton, Elizabeth and Kerridge, Ian and Newson, Ainsley and Farsides, Bobbie and Hammarberg, Karin and Hart, Roger and Jackson, Emily and Ledger, William and Mayes, Christopher and Mills, Catherine and Norcross, Sarah and Norman, Robert J and Rombauts, Luk and Waldby, Catherine and Yazdani, Anusch and Lipworth, Wendy},
title = {Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technology},
journal = {Reproductive BioMedicine Online},
year = {2024},
doi = {10.1016/j.rbmo.2024.103850}
}
EUVIMED